Fortis Healthcare Ltd Corporate Actions

Fortis Healthcare Q3 Profit Soars 89.5% YoY, Revenue Up 14.8%

 Copy Link

EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.

Fortis Healthcare Boosts Stake in Agilus Diagnostics with ₹429 Crore IFC Deal

 Copy Link

The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.

Fortis Healthcare Reports 1.6% Profit Growth, 12.3% Revenue Increase in Q2

 Copy Link

Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.

Fortis Buys Out PE Investors in Diagnostics Arm

 Copy Link

Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.